Abstract
Ischemia/reperfusion (I/R) occurs in a wide range of clinical scenarios including trauma, shock, transplantation, stroke, myocardial infarction, coronary angioplasty, thrombolytic therapy, coronary revascularization, and autoimmune diseases. Ischemia can cause tissue and organ damage due to an insufficient oxygen and glucose, which are necessary for cellular metabolism, which subsequently results in tissue or organ dysfunction. Although reperfusion is necessary to attenuate injury of ischemic tissues, it can trigger a cascade of events leading to additional tissue injury and even remote organ injury. Therefore, I/R injury contributes to the pathophysiology of a wide range of clinical diseases and is associated with considerable morbidity and mortality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
EstÃvariz CF, Griffith DP, Luo M, et al. Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients. J Parenter Enteral Nutr. 2008;32:389–402.
Kim M, Wischmeyer PE. Glutamine. World Rev Nutr Diet. 2013;105:90–6.
Demirkan A, Savaş B, Melli M. Endotoxin level in ischemia-reperfusion injury in rats: effect of glutamine pretreatment on endotoxin levels and gut morphology. Nutrition. 2010;26:106–1011.
Demirkan A, Orazakunov E, Savaş B, et al. Enteral glutamine pretreatment does not decrease plasma endotoxin level induced by ischemia-reperfusion injury in rats. World J Gastroenterol. 2008;14:463–8.
Medeiros AC, Chacon DA, Sales VS, et al. Glucan and glutamine reduce bacterial translocation in rats subjected to intestinal ischemia-reperfusion. J Invest Surg. 2006;19:39–46.
Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun. 1979;23:403–4011.
Kozar RA, Schultz SG, Hassoun HT, et al. The type of sodium-coupled solute modulates small bowel mucosal injury, transport function, and ATP after ischemia/reperfusion injury in rats. Gastroenterology. 2002;123:810–6.
Peng Z, Ban K, Sen A, et al. Syndecan 1 plays a novel role in enteral glutamine's gut-protective effects of the postischemic gut. Shock. 2012;38:57–62.
Kozar RA, Schultz SG, Bick RJ, et al. Enteral glutamine but not alanine maintains small bowel barrier function after ischemia/reperfusion injury in rats. Shock. 2004;21:433–7.
Sato N, Moore FA, Kone BC, et al. Differential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel. Am J Physiol Gastrointest Liver Physiol. 2006;290(4):G616–23.
Sato N, Moore FA, Smith MA, et al. Immune-enhancing enteral nutrients differentially modulate the early proinflammatory transcription factors mediating gut ischemia/reperfusion. J Trauma. 2005;58:455–4561.
Wu GH, Wang H, Zhang YW, et al. Glutamine supplemented parenteral nutrition prevents intestinal ischemia-reperfusion injury in rats. World J Gastroenterol. 2004;10:2592–4.
Harward TR, Coe D, Souba WW, et al. Glutamine preserves gut glutathione levels during intestinal ischemia/reperfusion. J Surg Res. 1994;56:351–5.
Ikeda S, Zarzaur BL, Johnson CD, et al. Total parenteral nutrition supplementation with glutamine improves survival after gut ischemia/reperfusion. J Parenter Enteral Nutr. 2002;26:169–73.
Omata J, Fukatsu K, Ueno C, et al. Intraluminal glutamine administration during ischemia worsens survival after gut ischemia-reperfusion. J Surg Res. 2007;143:260–4.
Fukatsu K, Ueno C, Hashiguchi Y, et al. Glutamine infusion during ischemia is detrimental in a murine gut ischemia/reperfusion model. J Parenter Enteral Nutr. 2003;27:187–92.
Mendes-Braz M, Elias-Miró M, Jiménez-Castro MB, et al. The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models. J Biomed Biotechnol. 2012;2012:298657.
Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, et al. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 2008;147:153–9.
Clavien PA, Selzner M, Rüdiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003;238:843–50.
Araújo Júnior RJ, Silva Júnior RG, et al. Preconditioning with l-alanyl-glutamine reduces hepatic ischemia-reperfusion injury in rats. Acta Cir Bras. 2011;26 Suppl 1:8–13.
Zhang SC, Shi Q, Feng YN, et al. Tissue-protective effect of glutamine on hepatic ischemia-reperfusion injury via induction of heme oxygenase-1. Pharmacology. 2013;91:59–68.
Schuster H, Blanc MC, Bonnefont-Rousselot D, et al. Protective effects of glutamine dipeptide and alpha-tocopherol against ischemia-reperfusion injury in the isolated rat liver. Clin Nutr. 2009;28:331–7.
Noh J, Behrends M, Choi S, et al. Glutamine does not protect against hepatic warm ischemia/reperfusion injury in rats. J Gastrointest Surg. 2006;10:234–9.
Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–146.
Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123:92–100.
Wischmeyer PE, Jayakar D, Williams U, et al. Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury. J Parenter Enteral Nutr. 2003;27:396–403.
Liu J, Marchase RB, Chatham JC. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels. J Mol Cell Cardiol. 2007;42:177–85.
Wischmeyer PE, Vanden Hoek TL, Li C, et al. Glutamine preserves cardiomyocyte viability and enhances recovery of contractile function after ischemia-reperfusion injury. J Parenter Enteral Nutr. 2003;27:116–22.
Pires VL, Souza JR, Guimarães SB, et al. Preconditioning with l-alanyl-l-glutamine in a Mongolian gerbil model of acute cerebral ischemia/reperfusion injury. Acta Cir Bras. 2011;26 Suppl 1:14–20.
Larson SD, Li J, Chung DH, et al. Molecular mechanisms contributing to glutamine-mediated intestinal cell survival. Am J Physiol Gastrointest Liver Physiol. 2007;293:G1262–71.
Ban K, Kozar RA. Glutamine protects against apoptosis via downregulation of Sp3 in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2010;299:G1344–53.
Santora R, Kozar RA. Molecular mechanisms of pharmaconutrients. J Surg Res. 2010;161:288–94.
Kelly D, Campbell JI, King TP, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol. 2004;5:104–12.
Mbodji K, Torre S, Haas V, et al. Alanyl-glutamine restores maternal deprivation-induced TLR4 levels in a rat neonatal model. Clin Nutr. 2011;30:672–7.
Wischmeyer PE, Kahana M, Wolfson R, et al. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol. 2001;90:2403–10.
Zhao Y, Patzer A, Gohlke P, et al. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain. Eur J Neurosci. 2005;22:278–82.
Sundararajan S, Gamboa JL, Victor NA, et al. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience. 2005;130:685–96.
Ban K, Sprunt JM, Martin S, et al. Glutamine activates peroxisome proliferator-activated receptor-γ in intestinal epithelial cells via 15-S-HETE and 13-OXO-ODE: a novel mechanism. Am J Physiol Gastrointest Liver Physiol. 2011;301:G547–54.
Fiatte C, Huin C, Collet P, et al. Expression of PPARgamma is reduced by medium supplementation with l-glutamine in human colorectal Caco-2 cells. Int J Mol Med. 2008;22:825–32.
Hassoun HT, Zou L, Moore FA, et al. Alpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2002;282:G1059–68.
Hassoun HT, Kozar RA, Kone BC, et al. Aischemic hypothermia differentially modulates oxidative stress proteins during mesenteric ischemia/reperfusion. Surgery. 2002;132:369–76.
Yeh KY, Yeh M, Glass J, et al. Rapid activation of NF-kappaB and AP-1 and target gene expression in postischemic rat intestine. Gastroenterology. 2000;118:525–34.
Zou L, Attuwaybi B, Kone BC. Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2003;284:G713–21.
Esposito E, Mondello S, Di Paola R, et al. Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats. Naunyn Schmiedebergs Arch Pharmacol. 2011;383:493–508.
Rao J, Qian X, Wang P, et al. All-trans retinoic acid preconditioning protects against liver ischemia/reperfusion injury by inhibiting the nuclear factor kappa B signaling pathway. J Surg Res. 2013;180:e99–106.
Chatterjee PK, Patel NS, Kvale EO, et al. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int. 2002;61:862–71.
Otterbein LE, Soares MP, Yamashita K, et al. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003;24:449–55.
Zhu X, Fan WG, Li DP, et al. Heme oxygenase-1 system and gastrointestinal inflammation: a short review. World J Gastroenterol. 2011;17:4283–8.
Tsuchihashi S, Zhai Y, Bo Q, et al. Heme oxygenase-1 mediated cytoprotection against liver ischemia and reperfusion injury: inhibition of type-1 interferon signaling. Transplantation. 2007;83:1628–34.
Teng YH, Aquino RS, Park PW. Molecular functions of syndecan-1 in disease. Matrix Biol. 2012;31:3–16.
Ricote M, Glass CK. PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta. 2007;1771:926–35.
Welch JS, Ricote M, Akiyama TE, et al. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci U S A. 2003;100:6712–9717.
Ricote M, Li AC, Willson TM, et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998;391:79–82.
Pautz A, Art J, Hahn S, et al. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide. 2010;23:75–93.
Cho MK, Suh SH, Kim SG. JunB/AP-1 and NF-kappa B-mediated induction of nitric oxide synthase by bovine type I collagen in serum-stimulated murine macrophages. Nitric Oxide. 2002;6:319–32.
Wang WP, Guo X, Koo MW, et al. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol. 2001;281:G586–94.
Ban K, Kozar RA. Enteral glutamine: a novel mediator of PPARgamma in the postischemic gut. J Leukoc Biol. 2008;84:595–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ban, K., Kozar, R.A. (2015). Protection by Glutamine After Ischemia/Reperfusion Injury. In: Rajendram, R., Preedy, V., Patel, V. (eds) Glutamine in Clinical Nutrition. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1932-1_35
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1932-1_35
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1931-4
Online ISBN: 978-1-4939-1932-1
eBook Packages: MedicineMedicine (R0)